Tecartus becomes first CAR T-cell therapy to receive FDA approval for adults with ALL

Rapid financing activity in the cell and gene therapy industry has exceeded $13 billion in 2021. Over half of this funding is from venture capital and...
https://www.google.com/url?rct=j&sa=t&url=https://www.scienceboard.net/index.aspx%3Fsec%3Dlog%26URL%3Dhttps%253A%252F%252Fwww.scienceboard.net%252Findex.aspx%253Fsec%253Dsup%2526sub%253DDrug%2526pag%253Ddis%2526ItemID%253D3389&ct=ga&cd=CAIyGmEyNDJjNTAxZWU3OTQyNzI6Y29tOmVuOlVT&usg=AFQjCNGN4iYazYlMR0_-vkI04CivAdT6Tg